MS patients face much greater risk of hospitalization, death from COVID-19, despite high rates of vaccination

New real-world research being presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27–30 April), reveals that people living with multiple sclerosis (MS) face a much higher risk of being hospitalized and dying from COVID-19 than the general population. The risk persists in individuals who received three or more vaccine doses.

Facebook Comments